Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods.
暂无分享,去创建一个
Z R Li | Z. R. Li | C W Yap | Y Z Chen | Y. Z. Chen | C. Yap | Yu Zong Chen
[1] Yoshitaka Yano,et al. Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis. , 2002, Journal of pharmaceutical sciences.
[2] A. J. Hopfinger,et al. Predicting Blood–Brain Barrier Partitioning of Organic Molecules Using Membrane–Interaction QSAR Analysis , 2002, Pharmaceutical Research.
[3] Z R Li,et al. Prediction of genotoxicity of chemical compounds by statistical learning methods. , 2005, Chemical research in toxicology.
[4] T Lavé,et al. Prediction of Hepatic Metabolic Clearance , 2001, Clinical pharmacokinetics.
[5] D J Rance,et al. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.
[6] Dennis H. Rouvray. Computational chemical graph theory , 1990 .
[7] Alexander Tropsha,et al. Quantitative structure-pharmacokinetic parameters relationships (QSPKR) analysis of antimicrobial agents in humans using simulated annealing k-nearest-neighbor and partial least-square analysis methods. , 2004, Journal of pharmaceutical sciences.
[8] Boris Hollas,et al. An Analysis of the Autocorrelation Descriptor for Molecules , 2003 .
[9] Igor V. Tetko,et al. Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..
[10] David J. Livingstone,et al. Data Analysis for Chemists: Applications to QSAR and Chemical Product Design , 1996 .
[11] Johann Gasteiger,et al. Deriving the 3D structure of organic molecules from their infrared spectra , 1999 .
[12] Paul Geladi,et al. Principal Component Analysis , 1987, Comprehensive Chemometrics.
[13] A. Tropsha,et al. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. , 2003, Journal of medicinal chemistry.
[14] Peter C Jurs,et al. Predicting the genotoxicity of thiophene derivatives from molecular structure. , 2003, Chemical research in toxicology.
[15] Han van de Waterbeemd,et al. Pharmacokinetics and metabolism in drug design , 2001 .
[16] Peter C. Jurs,et al. Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..
[17] György M Keseru,et al. A neural network based virtual screening of cytochrome P450 3A4 inhibitors. , 2002, Bioorganic & medicinal chemistry letters.
[18] Douglas M. Hawkins,et al. Assessing Model Fit by Cross-Validation , 2003, J. Chem. Inf. Comput. Sci..
[19] Roberto Todeschini,et al. Structure/Response Correlations and Similarity/Diversity Analysis by GETAWAY Descriptors, 1. Theory of the Novel 3D Molecular Descriptors , 2002, J. Chem. Inf. Comput. Sci..
[20] Panos Macheras,et al. Multivariate Statistics of Disposition Pharmacokinetic Parameters for Structurally Unrelated Drugs Used in Therapeutics , 2002, Pharmaceutical Research.
[21] L. Hall,et al. Molecular Structure Description: The Electrotopological State , 1999 .
[22] W. Pardridge,et al. CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport , 1998, Journal of neurochemistry.
[23] H Matter,et al. Random or rational design? Evaluation of diverse compound subsets from chemical structure databases. , 1998, Journal of medicinal chemistry.
[24] Johann Gasteiger,et al. The Coding of the Three-Dimensional Structure of Molecules by Molecular Transforms and Its Application to Structure-Spectra Correlations and Studies of Biological Activity , 1996, J. Chem. Inf. Comput. Sci..
[25] Yu Zong Chen,et al. Prediction of Cytochrome P450 3A4, 2D6, and 2C9 Inhibitors and Substrates by Using Support Vector Machines , 2005, J. Chem. Inf. Model..
[26] Richard A. Johnson,et al. Applied Multivariate Statistical Analysis , 1983 .
[27] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[28] S. Unger. Molecular Connectivity in Structure–activity Analysis , 1987 .
[29] G R Wilkinson,et al. Clearance approaches in pharmacology. , 1987, Pharmacological reviews.
[30] Michael H. Kutner. Applied Linear Statistical Models , 1974 .
[31] J. Ruuskanen,et al. Performance of (consensus) kNN QSAR for predicting estrogenic activity in a large diverse set of organic compounds , 2004, SAR and QSAR in environmental research.
[32] Tudor I. Oprea,et al. Chemography: the Art of Navigating in Chemical Space , 2000 .
[33] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[34] Jorge Gálvez,et al. Charge Indexes. New Topological Descriptors , 1994, J. Chem. Inf. Comput. Sci..
[35] Ing-Marie Olsson,et al. D-optimal onion designs in statistical molecular design , 2004 .
[36] Vladimir N. Vapnik,et al. The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.
[37] L. Kier. Indexes of molecular shape from chemical graphs , 1987, Medicinal research reviews.
[38] Ulf Norinder,et al. Support vector machine models in drug design: applications to drug transport processes and QSAR using simplex optimisations and variable selection , 2003, Neurocomputing.
[39] Bernhard Schölkopf,et al. A tutorial on support vector regression , 2004, Stat. Comput..
[40] Peter C. Jurs,et al. QSAR/QSPR Studies Using Probabilistic Neural Networks and Generalized Regression Neural Networks , 2002, J. Chem. Inf. Comput. Sci..
[41] Y. Z. Chen,et al. Quantitative Structure-Pharmacokinetic Relationships for drug distribution properties by using general regression neural network. , 2005, Journal of pharmaceutical sciences.
[42] Juan J Perez,et al. Managing molecular diversity. , 2005, Chemical Society reviews.
[43] E. Parzen. On Estimation of a Probability Density Function and Mode , 1962 .
[44] Subhash C. Basak,et al. Prediction of Complement-Inhibitory Activity of Benzamidines Using Topological and Geometric Parameters , 1999, J. Chem. Inf. Comput. Sci..
[45] Donald F. Specht,et al. A general regression neural network , 1991, IEEE Trans. Neural Networks.
[46] Bengt Rippe,et al. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. , 2005, American journal of physiology. Renal physiology.
[47] R. Obach,et al. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[48] M. Rami Reddy,et al. Assessment of methods used for predicting lipophilicity: Application to nucleosides and nucleoside bases , 1993, J. Comput. Chem..
[49] J. Zupan,et al. Separation of data on the training and test set for modelling: a case study for modelling of five colour properties of a white pigment , 2003 .
[50] Tomoko Niwa,et al. Using General Regression and Probabilistic Neural Networks To Predict Human Intestinal Absorption with Topological Descriptors Derived from Two-Dimensional Chemical Structures , 2003, J. Chem. Inf. Comput. Sci..
[51] Dennis A. Smith,et al. Properties of cytochrome P450 isoenzymes and their substrates Part 2: properties of cytochrome P450 substrates , 1997 .
[52] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[53] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[54] Gonzalo Colmenarejo,et al. In silico prediction of drug‐binding strengths to human serum albumin , 2003, Medicinal research reviews.
[55] Sean Ekins,et al. Pharmacophore modeling of cytochromes P450. , 2002, Advanced drug delivery reviews.
[56] Y. Sugiyama,et al. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[57] J. V. Turner,et al. Pharmacokinetic parameter prediction from drug structure using artificial neural networks. , 2004, International journal of pharmaceutics.
[58] T.W. Schultz,et al. Selection of data sets for qsars: Analyses of tetrahymena toxicity from aromatic compounds , 2003, SAR and QSAR in environmental research.
[59] Roberto Todeschini,et al. MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: A comparative 3D QSAR study in a series of steroids , 1997, J. Comput. Aided Mol. Des..
[60] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[61] Y. Yano,et al. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: oral clearance. , 2003, Journal of pharmaceutical sciences.
[62] A. Tsantili-Kakoulidou,et al. Quantitative structure-pharmacokinetic relationships for disposition parameters of cephalosporins. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[63] Snezana Agatonovic-Kustrin,et al. Multiple pharmacokinetic parameter prediction for a series of cephalosporins. , 2003, Journal of pharmaceutical sciences.
[64] Jeffrey J. Sutherland,et al. Spline-Fitting with a Genetic Algorithm: A Method for Developing Classification Structure-Activity Relationships , 2003, J. Chem. Inf. Comput. Sci..
[65] Jeffrey J. Sutherland,et al. Development of Quantitative Structure-Activity Relationships and Classification Models for Anticonvulsant Activity of Hydantoin Analogues , 2003, J. Chem. Inf. Comput. Sci..
[66] J. F. Wang,et al. Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach , 2004, J. Chem. Inf. Model..
[67] Zheng Yuan,et al. Prediction of protein accessible surface areas by support vector regression , 2004, Proteins.
[68] Juha Reunanen,et al. Overfitting in Making Comparisons Between Variable Selection Methods , 2003, J. Mach. Learn. Res..
[69] Y. Sugiyama,et al. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. , 1998, Annual review of pharmacology and toxicology.
[70] A. Kozak,et al. Does cross validation provide additional information in the evaluation of regression models , 2003 .
[71] Lemont B. Kier,et al. QSAR modeling of β-lactam binding to human serum proteins , 2003, J. Comput. Aided Mol. Des..